Abafungin

Abafungin

SCHEMBL301668

Cc1ccc(Oc2ccccc2-c2csc(N=C3NCCCN3)n2)c(C)c1

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ATP4A P20648 6/20 0.39
ATP4B P51164 6/20 0.39
HTR1A P08908 2/20 0.39
HTR3A P46098 2/20 0.39
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
ATM Q13315 2/20 0.34
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34
SCN9A Q15858 3/20 0.34
ALDH1A1 P00352 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CYP19A1 P11511 1/20 0.33
CYP17A1 P05093 1/20 0.33
ADRA1D P25100 1/20 0.32
ADRA1A P35348 1/20 0.32
ADRA1B P35368 1/20 0.32
PTGS2 P35354 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Abafungin SCHEMBL29517947 0.75 MEN1 (0.42) MAPTHTR1AHTR3AMEN1KMT2A
Abafungin SCHEMBL301669 0.75 MEN1 (0.42) MAPTHTR1AHTR3AMEN1KMT2A
Abafungin SCHEMBL10455902 0.74 MEN1 (0.41) MAPTHTR1AHTR3AMEN1KMT2A
SCHEMBL1064853 0.74 ATP4A (0.39) MAPTNPSR1ATP4AATP4BHTR3A
Abafungin SCHEMBL28095068 0.71 MEN1 (0.38) MAPTHTR1AHTR3AMEN1KMT2A
Abafungin SCHEMBL28223793 0.69 MEN1 (0.37) MAPTHTR1AHTR3AMEN1KMT2A
Abafungin SCHEMBL12795940 0.69 HTR1A (0.36) HTR1AHTR3ASCN9AADRA1DADRA1A
SCHEMBL8705879 0.69 MAPT (0.35) MAPTNPSR1ATP4AATP4BMEN1
SCHEMBL3605029 0.68 ATP4A (0.45) MAPTNPSR1ATP4AATP4BMEN1
SCHEMBL8705881 0.67 MAPT (0.41) MAPTNPSR1ATP4AATP4BNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3752 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4255391-B1 LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION METRIOPHARM AG (CH) 2026-05-06 EP claimed
US-20260102419-A1 USE OF COMPOUNDS IN THE TREATMENT OF FUNGAL INFECTIONS BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (CH) 2026-04-16 US claimed
EP-4719384-A2 COMPOUNDS WITH ANTIFUNGAL PROPERTIES Trustees of Dartmouth College (US) 2026-04-08 EP claimed
EP-4676500-A2 MICROBIAL CONSORTIA Kanvas Biosciences, Inc (US) 2026-01-14 EP claimed
US-20250268998-A1 METHODS OF TREATMENT FOR CANDIDA AURIS INFECTIONS LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER 2025-08-28 US claimed
US-12324830-B2 Methods of treatment for Candida auris infections LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER 2025-06-10 US claimed
US-12280032-B2 Methods and compositions for increasing the potency of antifungal agents PACIFIC NORTHWEST RESEARCH INSTITUTE (US) 2025-04-22 US claimed
WO-2025080590-A1 CO-CRYSTALLIZATION OF ACTIVES WITH SACCHARIDE-BASED MOLECULAR FRAMEWORKS SCIENTIFIC HORIZONS CONSULTING LLC (US) 2025-04-17 WO claimed
CN-114746415-B Polymorphs of triazole antifungal compound PC945 普尔莫赛德有限公司 2025-04-11 CN claimed
US-12269814-B2 Process for preparing a compound useful to treat mycoses PULMOCIDE LIMITED (GB) 2025-04-08 US claimed
CN-101711755-A Pressure sensitive adhesive matrix patch device for treating or preventing onychomycosis or tinea pedis TAIWAN BIOTECH CO LTD 2010-05-26 CN claimed
US-20100081669-A1 PRESSURE SENSITIVE ADHESIVE MATRIX DEVICE OR SYSTEM FOR THE TREATMENT OR PREVENTION OF ONYCHOMYCOSIS OR TINEA PEDIS TAIWAN BIOTECH CO., LTD. (TW) 2010-04-01 US claimed
WO-2009053741-A2 NOVEL FORMULATION YORK PHARMA PLC (GB) 2009-04-30 WO claimed
CN-101396363-A Composite antibacterial drugs composition containing abafungin CHONGQING PHARMACEUTICAL RESEA (CN) 2009-04-01 CN claimed
CN-101372486-A Preparation of abafungin and analogues thereof CHENGDU QIAOFENG TECHNOLOGICAL (CN) 2009-02-25 CN claimed
EP-1682146-B1 ANTIMYCOTIC NAIL POLISH FORMULATIONS COMPRISING SUBSTITUTED 2-AMINOTHIAZOLES AS AN ACTIVE SUBSTANCE YORK PHARMA PLC (GB) 2008-01-09 EP claimed
CN-1969874-A Externally applied pharmaceutical composition of abafungin CHONGQING PHARM RES INST CO (CN) 2007-05-30 CN claimed
US-20070059261-A1 Antimycotic nail polish formulations comprising substituted 2-aminothiazoles as an active substance ULURU INC. 2007-03-15 US claimed
EP-1682146-A1 ANTIMYCOTIC NAIL POLISH FORMULATIONS COMPRISING SUBSTITUTED 2-AMINOTHIAZOLES AS AN ACTIVE SUBSTANCE York Pharma PLC (GB) 2006-07-26 EP claimed
WO-2005034956-A1 ANTIMYCOTIC NAIL POLISH FORMULATIONS COMPRISING SUBSTITUTED 2-AMINOTHIAZOLES AS AN ACTIVE SUBSTANCE YORK PHARMA PLC (GB) 2005-04-21 WO claimed